BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20298175)

  • 1. Barrett's metaplasia: molecular mechanisms and nutritional influences.
    Slack JM; Colleypriest BJ; Quinlan JM; Yu WY; Farrant MJ; Tosh D
    Biochem Soc Trans; 2010 Apr; 38(2):313-9. PubMed ID: 20298175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Cdx2 in Barrett's metaplasia.
    Colleypriest BJ; Farrant JM; Slack JM; Tosh D
    Biochem Soc Trans; 2010 Apr; 38(2):364-9. PubMed ID: 20298184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development.
    Kazumori H; Ishihara S; Kinoshita Y
    Gut; 2009 May; 58(5):620-8. PubMed ID: 19136512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.
    Kazumori H; Ishihara S; Rumi MA; Kadowaki Y; Kinoshita Y
    Gut; 2006 Jan; 55(1):16-25. PubMed ID: 16118348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
    Souza RF; Krishnan K; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells.
    Hu Y; Williams VA; Gellersen O; Jones C; Watson TJ; Peters JH
    J Gastrointest Surg; 2007 Jul; 11(7):827-34. PubMed ID: 17458588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics.
    Ostrowski J; Mikula M; Karczmarski J; Rubel T; Wyrwicz LS; Bragoszewski P; Gaj P; Dadlez M; Butruk E; Regula J
    J Mol Med (Berl); 2007 Jul; 85(7):733-43. PubMed ID: 17415542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
    Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
    Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hnf4α is a key gene that can generate columnar metaplasia in oesophageal epithelium.
    Colleypriest BJ; Burke ZD; Griffiths LP; Chen Y; Yu WY; Jover R; Bock M; Biddlestone L; Quinlan JM; Ward SG; Mark Farrant J; Slack JMW; Tosh D
    Differentiation; 2017; 93():39-49. PubMed ID: 27875772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
    Souza RF
    J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
    Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
    Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of Barrett's esophagus--new findings in the experimental studies of duodenal reflux models].
    Hattori T; Mukaisho K; Miwa K
    Nihon Rinsho; 2005 Aug; 63(8):1341-9. PubMed ID: 16101219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Kruppel-like factor 4 in oesophageal epithelial cells in Barrett's epithelium development.
    Kazumori H; Ishihara S; Takahashi Y; Amano Y; Kinoshita Y
    Gut; 2011 May; 60(5):608-17. PubMed ID: 21193454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P63 Deficiency and CDX2 Overexpression Lead to Barrett's-Like Metaplasia in Mouse Esophageal Epithelium.
    Fang Y; Li W; Chen X
    Dig Dis Sci; 2021 Dec; 66(12):4263-4273. PubMed ID: 33469811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour.
    Watanabe G; Ajioka Y; Takeuchi M; Annenkov A; Kato T; Watanabe K; Tani Y; Ikegami K; Yokota Y; Fukuda M
    Histopathology; 2015 Jan; 66(2):201-14. PubMed ID: 25040564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
    Phillips RW; Frierson HF; Moskaluk CA
    Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett's esophagus.
    Kong J; Crissey MA; Funakoshi S; Kreindler JL; Lynch JP
    PLoS One; 2011 Apr; 6(4):e18280. PubMed ID: 21494671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.